These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
105 related articles for article (PubMed ID: 2603451)
21. Carboplatin dose calculation in lung cancer patients with low serum creatinine concentrations using CKD-EPI and Cockcroft-Gault with different weight descriptors. Kaag D Lung Cancer; 2013 Jan; 79(1):54-8. PubMed ID: 23131495 [TBL] [Abstract][Full Text] [Related]
22. A weight-related intravenous dexamethasone suppression test distinguishes obese controls from patients with Cushing's syndrome. Atkinson AB; McAteer EJ; Hadden DR; Kennedy L; Sheridan B; Traub AI Acta Endocrinol (Copenh); 1989 Jun; 120(6):753-9. PubMed ID: 2728813 [TBL] [Abstract][Full Text] [Related]
23. Correlation between insulin clearance and insulin responsiveness: studies in normal, obese, hyperthyroid, and Cushing's syndrome patients. Cohen P; Barzilai N; Barzilai D; Karnieli E Metabolism; 1986 Aug; 35(8):744-9. PubMed ID: 3526086 [TBL] [Abstract][Full Text] [Related]
25. A comparison of adrenal cortical function in patients with depressive illness and Cushing's disease. Schlechte JA; Sherman B; Pfohl B Horm Res; 1986; 23(1):1-8. PubMed ID: 3940937 [TBL] [Abstract][Full Text] [Related]
26. Performance of creatinine clearance equations on the original Cockcroft-Gault population. Shoker A; Hossain MA; Koru-Sengul T; Raju DL; Cockcroft D Clin Nephrol; 2006 Aug; 66(2):89-97. PubMed ID: 16939064 [TBL] [Abstract][Full Text] [Related]
27. Estimation of body fat and lean tissue distribution by dual energy X-ray absorptiometry and abdominal body fat evaluation by computed tomography in Cushing's disease. Wajchenberg BL; Bosco A; Marone MM; Levin S; Rocha M; Lerário AC; Nery M; Goldman J; Liberman B J Clin Endocrinol Metab; 1995 Sep; 80(9):2791-4. PubMed ID: 7673425 [TBL] [Abstract][Full Text] [Related]
28. A comparison of the use of urinary cortisol to creatinine ratios and nocturnal salivary cortisol in the evaluation of cyclicity in patients with Cushing's syndrome. Graham UM; Hunter SJ; McDonnell M; Mullan KR; Atkinson AB J Clin Endocrinol Metab; 2013 Jan; 98(1):E72-6. PubMed ID: 23150688 [TBL] [Abstract][Full Text] [Related]
29. Comparison of creatinine clearance estimation methods in patients with trauma. Davis GA; Chandler MH Am J Health Syst Pharm; 1996 May; 53(9):1028-32. PubMed ID: 8744465 [TBL] [Abstract][Full Text] [Related]
30. Assessment of cortisol and ACTH responses to the desmopressin test in patients with Cushing's syndrome and simple obesity. Tsagarakis S; Vasiliou V; Kokkoris P; Stavropoulos G; Thalassinos N Clin Endocrinol (Oxf); 1999 Oct; 51(4):473-7. PubMed ID: 10583315 [TBL] [Abstract][Full Text] [Related]
31. Relationship of bioassayable and immunoassayable plasma ACTH and cortisol concentrations in normal subjects and in patients with Cushing's disease. Krieger DT; Allen W J Clin Endocrinol Metab; 1975 Apr; 40(4):675-87. PubMed ID: 165214 [TBL] [Abstract][Full Text] [Related]
32. [Comparison between the value of urinary free cortisol and 17-hydroxycorticosteroids for the diagnosis of Cushing's syndrome]. Billon-Rey S; Beylot M; Mathian B; Patricot MC; Berthezene F; Mornex R; Revol A Presse Med; 1986 May; 15(21):965-8. PubMed ID: 2942852 [TBL] [Abstract][Full Text] [Related]
33. Body Composition Analysis Allows the Prediction of Urinary Creatinine Excretion and of Renal Function in Chronic Kidney Disease Patients. Donadio C Nutrients; 2017 May; 9(6):. PubMed ID: 28555040 [TBL] [Abstract][Full Text] [Related]
34. The glomerular filtration rate: comparison of various predictive equations based on serum creatinine with conventional creatinine clearance test in Pakistani population. Zubairi AM; Hussain A J Pak Med Assoc; 2008 Apr; 58(4):182-5. PubMed ID: 18655426 [TBL] [Abstract][Full Text] [Related]
35. Leucine metabolism in patients with Cushing's syndrome before and after successful treatment. Bowes SB; Benn JJ; Scobie IN; Umpleby AM; Lowy C; Sönksen PH Clin Endocrinol (Oxf); 1993 Nov; 39(5):591-8. PubMed ID: 8252750 [TBL] [Abstract][Full Text] [Related]
36. Plasma ACTH and cortisol responses to TRF, vasopressin or hypoglycemia in cushing's disease and nelson's syndrome. Krieger DT; Luria M J Clin Endocrinol Metab; 1977 Feb; 44(2):361-8. PubMed ID: 190254 [TBL] [Abstract][Full Text] [Related]
38. Spot determinations of urinary cortisol for the screening of Cushing's syndrome. Fujita H; Hata K; Ogata E; Kojima I Endocrinol Jpn; 1991 Aug; 38(4):441-4. PubMed ID: 1802685 [TBL] [Abstract][Full Text] [Related]
39. Creatinine clearance can be predicted from plasma creatinine and body composition analysis by means of electrical bioimpedance. Donadio C; Lucchesi A; Tramonti G; Bianchi C Ren Fail; 1998 Mar; 20(2):285-93. PubMed ID: 9574454 [TBL] [Abstract][Full Text] [Related]
40. [ACTH secretion and adrenocortical responsiveness in Cushing's syndrome due to adrenocortical hyperplasia (author's transl)]. Suzuki S Nihon Naibunpi Gakkai Zasshi; 1976 Aug; 52(8):828-44. PubMed ID: 190054 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]